Beckman Coulter Life Sciences at this time introduced RNAdvance Viral XP has been added to the listing of acceptable extraction strategies to be used within the Facilities for Illness Management’s EUA-authorized COVID-19 check referenced within the FDA’s FAQ on testing for SARS-CoV-2. Laboratories are actually permitted to independently validate RNAdvance Viral XP to be used.
The extraction of RNA from viral samples is a crucial step for pathogen analysis and detection to allow correct downstream assay outcomes. Beckman Coulter Life Sciences has remained dedicated to growing high-performing, scalable reagents for laboratories testing COVID-19 affected person swab samples.
RNA extraction is important at this time for dependable COVID-19 testing. RNA extraction removes contaminants from the pattern, which might intrude with the qRT-PCR check and lead to a false damaging.”
Thomas Marshall, Ph.D., Genomics R&D Chief, Beckman Coulter Life Sciences
In March, Beckman Coulter Life Sciences printed two demonstrated RNA extraction strategies for viral samples. Then, earlier this month, the corporate formally launched RNAdvance Viral XP as a reagent package for analysis use.
Our crew has labored diligently with clients and authorities entities to develop, refine and validate confirmed viral extraction reagents throughout this time of elevated want. The complete Beckman Coulter Life Sciences household is proud our expertise can now be used to broaden COVID-19 testing capabilities in laboratories world wide for the foreseeable future.”
Greg Milosevich, President, Beckman Coulter Life Sciences
— to www.news-medical.net